MLXIPL and fatty liver disease: Since the effects of sucralose on hepatic steatosis were observed in mice, we then evaluated the levels of lipogenesis protein expressions in the liver, such as ChREBP (Figure 3A), SREBP1 (Figure 3B), FASN (Figure 3C), and ACC (Figure 3D).